Thyroid Function in Korean Adolescents with Obesity: Results from the Korea National Health and Nutrition Examination Survey VI (2013–2015)

Cho, Won Kyoung; Nam, Hyo-Kyoung; Kim, Jae Hyun; Rhie, Young-Jun; Chung, Sochung; Lee, Kee-Hyoung; Suh, Byung-Kyu

doi:https://doi.org/10.1155/2018/6874395

International Journal of Endocrinology

On this page

Abstract Introduction Materials and Methods Results Data Availability Ethical Approval Consent Conflicts of Interest References Copyright Related Articles

Research Article | Open Access

Volume 2018 | Article ID 6874395 | https://doi.org/10.1155/2018/6874395

Thyroid Function in Korean Adolescents with Obesity: Results from the Korea National Health and Nutrition Examination Survey VI (2013–2015)

Won Kyoung Cho,¹Hyo-Kyoung Nam,²Jae Hyun Kim,³Young-Jun Rhie,⁴Sochung Chung,⁵Kee-Hyoung Lee,⁶and Byung-Kyu Suh⁷

Academic Editor: Giorgio Iervasi

Received12 Apr 2018

Revised20 Jul 2018

Accepted06 Aug 2018

Published03 Sept 2018

Abstract

Purpose. In this study, we investigated the status of thyroid function and its association with metabolic risk factors in Korean adolescents. Methods. Among 2679 subjects aged 10–19 years who participated in the Korea National Health and Nutrition Examination Survey VI (2013–2015), 1067 adolescents (, ) with available data on free T4 (FT4) and thyroid-stimulating hormone (TSH) were included. Study participants were classified into normal weight [body mass index (BMI) below 85th percentile, 80.7%], overweight (85th ≤ BMI< 95th percentile, 8.7%), and obesity (BMI ≥ 95th percentile, 10.6%). Results. With increasing levels of BMI category, the means of TSH increased (2.73 ± 0.06, 2.77 ± 0.02, and 3.24 ± 0.22 mIU/L, ) and FT4 decreased (1.30 ± 0.01, 1.26 ± 0.02, and 1.25 ± 0.02 ng/mL, ). Positive linear associations were observed between TSH and BMI z-score (), waist circumference (), waist-height ratio (), systolic blood pressure (), total cholesterol (), and triglyceride () after adjusting for age and sex. With per-unit increase in TSH, the odds ratios of having abdominal obesity (OR = 1.18, 95% CI, 1.01–1.38) and triglyceride ≥ 150 mg/dL (OR = 1.18, 95% CI, 1.04–1.34) were significantly increased after adjusting for age, sex, and BMI. Conclusions. In adolescents with obesity, TSH was higher and FT4 was lower than in adolescents with normal weight. Hyperthyrotropinemia was associated with abnormal metabolic risk factors including abdominal obesity and elevated triglyceride.

1. Introduction

The prevalence of childhood obesity has significantly increased worldwide and has become an important global public health issue [1]. Childhood obesity is a major health concern, and endocrinopathies including thyroid dysfunction have been frequently reported. Obesity occurs when energy intake exceeds energy expenditure [2]. It is well established that thyroid hormone (TH) status correlates with body weight and energy expenditure [3, 4]. TH maintains basal metabolic rate, facilitates adaptive thermogenesis, modulates appetite and food intake, and regulates body weight [5].

Some cross-sectional studies have shown an association between high body mass index (BMI) and low levels of free T4 (FT4) or high levels of triiodothyronine (T3) and thyroid-stimulating hormone (TSH) within the euthyroid range [6, 7]. In adolescents with obesity, the most common thyroid abnormality is subclinical hyperthyrotropinemia [8–10]. Sometimes, subclinical hyperthyrotropinemia in subjects with obesity often may lead to a premature diagnosis of subclinical hypothyroidism and result in the initiation of inappropriate TH administration [11]. Reasons for hyperthyrotropinemia in adolescents with obesity remain unclear [12]. However, since alterations in levels of thyroid function test were often normalized with weight loss, they seem to be a reversible consequence of the weight status [10, 13]. The well-supported hypothesis explaining hyperthyrotropinemia in subjects with obesity is an adaptation process to increase energy expenditure for reducing the availability of energy for conversion into fat [12, 14].

Few reports are available regarding the relationship between obesity and thyroid function in Korean adolescents. Furthermore, there is still a lack of data regarding the relationship between thyroid function and other metabolic risk factors in children with obesity. In this study, we conducted a cross-sectional study based on data obtained in the 2013–2015 Korea National Health and Nutrition Examination Surveys (KNHANES) to investigate the status of thyroid function and its association with metabolic risk factors in Korean adolescents.

2. Materials and Methods

2.1. Data

Data was obtained from the KNHANES conducted between 2013 and 2015 by the Korean Ministry of Health and Welfare. The KNHANES are conducted annually using a rolling sampling design that involves a complex, stratified, multistage, and probability-cluster survey of a representative sample of the noninstitutionalized civilian population in South Korea. All individuals are randomly selected. Data was collected in a variety of ways, including household interviews, physical examinations, laboratory tests, and nutritional status assessments. The KNHANES data are publicly available with no charge [15].

2.2. Selection of the Study Population

In the 2013–2015 KNHANES, thyroid function test including FT4, TSH, and anti-thyroid peroxidase antibody (TPOAb) were performed on 2400 subjects aged ≥10 years old after subsampling of total study participants. Among 2679 subjects aged 10–19 years who participated in the 2013–2015 KNHANES, thyroid function tests were performed on 1135 subjects. Of these 1135 subjects, abnormal levels of FT4 (), positive TPOAb (), and inappropriate fasting states for laboratory measurements () were excluded. Ultimately, our study population included 1067 adolescents (, ) (Figure 1).

2.3. Anthropometric and Laboratory Measurements

Height was measured using a stadiometer (Seca225, Seca, Hamburg, Germany), and weight was measured with a balance beam scale (GL-6000-20, G-tech, Seoul, Korea) with participants wearing standard gowns. BMI was calculated as weight (kg) divided by height (m) squared. BMI data were calculated to z-score based on Korean reference data [16]. Waist circumference (WC) was measured to the nearest 0.1 cm at the end of normal expiration from the narrowest point between the midline of the most lateral border of the right and left iliac crest. Waist-height ratio (WHR) was calculated as WC (cm) divided by height (cm) and expressed as a percentage (%). Fasting plasma concentrations including glucose, total cholesterol (TC), triglyceride (TG), high-density lipoprotein-cholesterol (HDL-C), aspartate transaminase (AST), and alanine transaminase (ALT) were measured enzymatically using a Hitachi Automatic Analyzer 7600 (Hitachi, Tokyo, Japan) after subjects completed a minimum 8-hour overnight fast. Glycosylated hemoglobin (HbA1c) was measured using high-performance liquid chromatography (HLC-723G7; Tosoh, Tokyo, Japan), which is the method certified by the National Glycohemoglobin Standardization Program. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured using a mercury sphygmomanometer [Baumanometer Wall Unit 33(0850), W.A. Baum, New York, USA] according to the standardized protocol by trained personnel. An appropriately sized BP cuff was applied based on participants’ arm circumference. BP was measured three times after sitting at least 5 minutes. The mean value of the last two readings was used for the analysis.

For analyzing the serum levels of TSH, FT4, and TPOAb, approximately 15 mL of blood was collected. After 30 minutes of separation of the serum, each sample was transferred to the testing facility and analyzed within 24 hours of collection. Serum TSH, FT4, and TPOAb levels were measured with an electrochemiluminescence immunoassay (Roche Diagnostics, Mannheim, Germany) after subjects completed a minimum 8-hour overnight fast. TSH was measured using an E-TSH kit (Roche Diagnostics), for which the reference range was 0.35 to 5.50 mIU/L. The FT4 was measured using an E-Free T4 kit (Roche Diagnostics), for which the reference range was 0.89 to 1.76 ng/mL. TPOAb was measured using an E-Anti-TPO kit (Roche Diagnostics); the normal range for TPOAb in humans is <34.0 IU/mL. The results for TSH, FT4, and TPOAb met specifications regarding accuracy, general chemistry, special immunology, and ligands established by the quality control and assurance program of the College of American Pathologists [17].

2.4. Study Criteria

Subclinical hyperthyrotropinemia was defined as elevated TSH (TSH > 5.5 IU/L) with normal FT4. A subject was classified as normal weight (below 85th percentile BMI for corresponding age and sex), overweight (85th ≤ BMI < 95th percentile for corresponding age and sex), or obese (BMI ≥ 95th percentile for corresponding age and sex) according to the 2017 Korea National Growth Charts [16]. Criteria for abnormal metabolic risk factors were adopted from those of components of metabolic syndrome defined by the International Diabetes Federation. WC ≥ 90th percentile for age and sex was used to diagnose abdominal obesity. Cut-off values of abnormal metabolic risk factors in adolescents were as follows: HDL-C < 40 mg/dL in boys and girls aged ≤15 years or <50 mg/dL in girls older than 16 years; TG ≥ 150 mg/dL; fasting glucose ≥ 100 mg/dL; SBP ≥ 130 mmHg or DBP ≥ 85 mmHg [18, 19].

2.5. Statistical Analyses

All statistical analyses were performed using Stata 14.2 software (StataCorp LP, College Station, TX, USA). Sampling weights were incorporated to produce valid population estimates that accounted for the complex survey design of the KNHANES. Data are presented as weighted mean ± standard error (SE) for continuous variables and frequency with weighted percentage for categorical variables. The anthropometric characteristics and laboratory data were compared between groups according to BMI category using linear regression analysis for continuous measures and logistic regression analysis for categorical measures. Multiple linear regression analysis was adjusted for age and sex to investigate relationships between TSH concentration and cardiometabolic risk factors. Multiple logistic regression models were used to calculate the adjusted odds ratio (OR) and 95% confidence interval (CI) for predicting the presence of metabolic risk factors by TSH concentrations after adjusting for potentially confounding variables. values less than 0.05 were considered as statistically significant.

3. Results

3.1. Thyroid Function and Metabolic Risk Factors according to Increasing Levels of BMI Category in 10–19-Year-Old Korean Adolescents

The prevalence of Korean adolescents with normal weight, overweight, and obesity was 80.7% (), 8.7% (), and 10.6% (), respectively. With increasing levels of BMI category, the means of BMI ( for trend < 0.001), BMI z-score ( for trend < 0.001), WC ( for trend < 0.001), WHR ( for trend < 0.001), SBP ( for trend = 0.001), TC ( for trend = 0.004), TG ( for trend < 0.001), AST ( for trend = 0.043), ALT ( for trend < 0.001), and TSH ( for trend = 0.031) increased significantly (Table 1). With increasing levels of BMI category, the means of HDL-C ( for trend < 0.001) and FT4 ( for trend = 0.001) decreased (Table 1). Figure 2 showed the distribution of TSH by BMI category. Among the three groups, there was no significant difference in the means of age, fasting glucose, HbA1c, and DBP (Table 1).

3.2. Linear Associations between Serum TSH Level and Metabolic Risk Factors in 10–19-Year-Old Korean Adolescents

Serum TSH level showed positive linear associations with BMI z-score (, ), WHR (, ), SBP (, ), fasting glucose (, ), TC (, ), and TG (, ), but no significant associations were observed with DBP, HbA1c, HDL-C, and ALT. After adjusting for age and sex, positive linear associations were persistently observed between serum TSH level and BMI z-score (, ), WC (, ), WHR (, ), SBP (, ), TC (, ), and TG (, ), but not with DBP, HbA1c, fasting glucose, and HDL-C (Table 2).

3.3. Multivariate Logistic Analyses of Having Metabolic Risk Factors according to Per-Unit Increase in TSH

In Korean adolescents, the odds ratios of having metabolic risk factors including abdominal obesity (OR = 1.22, 95% CI, 1.10–1.36), obesity (OR = 1.19, 95% CI, 1.05–1.35), and TG ≥ 150 mg/dL (OR = 1.21, 95% CI, 1.07–1.36) according to per-unit increase in TSH were significantly increased (model 1). The odds ratios of having abdominal obesity (OR = 1.18, 95% CI, 1.01–1.38) and TG ≥ 150 mg/dL (OR = 1.18, 95% CI, 1.04–1.34) according to per-unit increase in TSH were persistently observed after adjusting for age, sex, and BMI (model 3) (Table 3).

4. Discussions

In the present study, the serum TSH level in adolescents with obesity was higher than that in adolescents with normal weight. Suggested causes of subclinical hyperthyrotropinemia in a person with obesity are iodine deficiency, thyroid autoimmunity, mitochondrial dysfunction, thyroid hormone resistance, mutation in the TSH-receptor gene, impaired hypothalamic pituitary axis, or adaptation of increased energy expenditure mediated by leptin [12, 20–22]. However, hyperthyrotropinemia in obese subjects is usually not associated with iodine deficiency or autoimmune thyroiditis [10]. In our study, participants with positive TPOAb were excluded. Furthermore, mutations in the TSH-receptor gene are very rare [23]. Overall, the most favored hypothesis attempting to explain the hyperthyrotropinemia in subjects with obesity is the increased leptin-mediated production of pro-thyrotropin-releasing hormone (TRH) [14, 23].

Obesity is associated with serum leptin levels [24]. In addition to TRH/TSH regulation by TH feedback, there is central modulation by nutritional signals. Leptin is a known regulator of TRH and TSH secretion via direct action on the paraventricular nucleus and indirect action on the arcuate nucleus [25]. In the hypothalamus, leptin might increase thermogenesis by regulating TRH neurons [26]. Mantzoros et al. showed that leptin and plasma TSH levels are both highly organized and pulsatile, with similar circadian rhythms, and using a cosinor analysis, they showed near-superimposable peak values [27]. On the other hand, some reports suggested that TSH stimulates leptin secretion via a direct effect on adipocytes [28]. These complex and dual relationships between leptin and the thyroid axis left open the possibility that hyperthyrotropinemia in obese subjects may be affected by regulation of leptin pulses.

In the present study, the serum FT4 level in adolescents with obesity was lower than that in the normal weight group. Previous studies have also reported the decreased serum FT4 level within the normal range in obese subjects [29]. The involved mechanisms are not clear although these alterations have been explained by increased deiodinase activity in obesity. Local conversion of thyroxine (T4) to T3 by 5-deiodinase type 2 (D2) is a key mechanism of TH regulation [5]. The high conversion rate of T4 to T3 in subjects with obesity has been also interpreted as a defense mechanism, capable of counteracting the accumulation of fat by increasing the basal metabolic rate, positively related to the levels of total T3 and free T3 [30, 31]. Leptin has been also shown to regulate D2 in different tissues, depending on energetic status, thus promoting the conversion of T4 to T3 [21, 32].

We found that the ORs of having abdominal obesity, obesity, and hyper TG were increased according to the per-unit increase in TSH in Korean adolescents. Some reports suggest the correlations between hyperthyrotropinemia and TG, insulin resistance, and DBP in obese adolescents [25, 33]. Emerging evidence identifies a role for TH in metabolism of lipids, carbohydrates, proteins, and heat production [12]. Some suggest that the associations between hyperthyrotropinemia and lipid profiles in children with obesity are secondary to weight status rather than thyroid dysfunction [34]. However, in our study, correlations between serum levels of TSH and TG in multiple regression analysis still persist significantly after adjusting BMI. This significant association between hyperthyrotropinemia with TG might support the role for TH in metabolism of lipids.

There are some limitations in this study. We did not have data on serum T3 and leptin levels. Because of the cross-sectional design of this study, long-term consequences of hyperthyrotropinemia in obese adolescents could not be elucidated. However, to the best of our knowledge, this is the first study to show the status of thyroid function and the association with metabolic risk factors in Korean adolescents with obesity, which was based on the reliable large-scale nationally representative dataset.

In conclusion, a higher serum TSH and lower FT4 level was observed in Korean adolescents with obesity than in those with normal weight. Positive linear associations were observed between serum TSH levels and BMI-SDS, WC, WHR, SBP, TC, and TG after adjusting for age and sex. We also found increased odds ratios of having abdominal obesity, hyper TG, and obesity according to the per-unit increase in TSH after adjusting for age, sex, and BMI. Further investigation focusing on the hypothalamus-pituitary-thyroid axis and metabolic risk factors in obese children including energy metabolism with a large data set is necessary.

Data Availability

The raw data used to support the findings of this study are available at the KNHANES webpage (https://knhanes.cdc.go.kr/knhanes/eng/index.do). Requests for access to these data could be directed to the officer at the Korea Centers for Disease Control and Prevention ([email protected]; +82-43-719-7467).

Ethical Approval

All participants provided informed consent for the genetic study. This study was approved by the Institutional Review Board (IRB) of The Catholic University of Korea (KC17EISE0017).

All survey protocols were approved by the Korea Centers for Disease Control and Prevention Institutional Review Board. Written informed consent was obtained from all participants before the survey began.

Conflicts of Interest

The authors declare that they have no competing interests.

References

T. Lob-Corzilius, “Overweight and obesity in childhood—a special challenge for public health,” International Journal of Hygiene and Environmental Health, vol. 210, no. 5, pp. 585–589, 2007.
View at: Publisher Site | Google Scholar
Y. H. Tseng, A. M. Cypess, and C. R. Kahn, “Cellular bioenergetics as a target for obesity therapy,” Nature Reviews Drug Discovery, vol. 9, no. 6, pp. 465–482, 2010.
View at: Publisher Site | Google Scholar
K. A. Iwen, E. Schroder, and G. Brabant, “Thyroid hormones and the metabolic syndrome,” European Thyroid Journal, vol. 2, no. 2, pp. 83–92, 2013.
View at: Publisher Site | Google Scholar
C. S. Fox, M. J. Pencina, R. B. D'Agostino et al., “Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample,” Archives of Internal Medicine, vol. 168, no. 6, pp. 587–592, 2008.
View at: Publisher Site | Google Scholar
R. Mullur, Y. Y. Liu, and G. A. Brent, “Thyroid hormone regulation of metabolism,” Physiological Reviews, vol. 94, no. 2, pp. 355–382, 2014.
View at: Publisher Site | Google Scholar
Y. Lai, J. Wang, F. Jiang et al., “The relationship between serum thyrotropin and components of metabolic syndrome,” Endocrine Journal, vol. 58, no. 1, pp. 23–30, 2011.
View at: Publisher Site | Google Scholar
H. Bilgin and O. Pirgon, “Thyroid function in obese children with non-alcoholic fatty liver disease,” Journal of Clinical Research in Pediatric Endocrinology, vol. 6, no. 3, pp. 152–157, 2014.
View at: Publisher Site | Google Scholar
B. Biondi, “Thyroid and obesity: an intriguing relationship,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 8, pp. 3614–3617, 2010.
View at: Publisher Site | Google Scholar
V. Marras, M. R. Casini, S. Pilia et al., “Thyroid function in obese children and adolescents,” Hormone Research in Pædiatrics, vol. 73, no. 3, pp. 193–197, 2010.
View at: Publisher Site | Google Scholar
I. Aeberli, A. Jung, S. B. Murer et al., “During rapid weight loss in obese children, reductions in TSH predict improvements in insulin sensitivity independent of changes in body weight or fat,” The Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 12, pp. 5412–5418, 2010.
View at: Publisher Site | Google Scholar
H. Stichel, D. l'Allemand, and A. Gruters, “Thyroid function and obesity in children and adolescents,” Hormone Research in Paediatrics, vol. 54, no. 1, pp. 14–19, 2000.
View at: Publisher Site | Google Scholar
T. Reinehr, “Obesity and thyroid function,” Molecular and Cellular Endocrinology, vol. 316, no. 2, pp. 165–171, 2010.
View at: Publisher Site | Google Scholar
T. Reinehr, G. de Sousa, and W. Andler, “Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids,” The Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 3088–3091, 2006.
View at: Publisher Site | Google Scholar
L. H. Duntas and B. Biondi, “The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin,” Thyroid, vol. 23, no. 6, pp. 646–653, 2013.
View at: Publisher Site | Google Scholar
Korea Centers for Disease Control and Prevention, “Korean National Health and Nutrition Examination Survey,” February 2018, https://knhanes.cdc.go.kr/knhanes/eng/index.do.
View at: Google Scholar
J. H. Kim, S. Yun, S. S. Hwang et al., “The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects,” Korean Journal of Pediatrics, vol. 61, no. 5, pp. 135–149, 2018.
View at: Publisher Site | Google Scholar
Foundation MotISM, “Laboratory medicine of the Korea National Health and Nutrition Examination Survey VI (2013–2015),” February 2018, http://www.prism.go.kr/homepage/entire/retrieveEntireDetail.do?pageIndex=1&research_id=1351000-201500293&leftMenuLevel=160&cond_research_name=%EC%A0%9C6%EA%B8%B0&cond_research_start_date=&cond_research_end_date=&pageUnit=10&cond_order=3.
View at: Google Scholar
S. Cook, M. Weitzman, P. Auinger, M. Nguyen, and W. H. Dietz, “Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994,” Archives of Pediatrics & Adolescent Medicine, vol. 157, no. 8, pp. 821–827, 2003.
View at: Publisher Site | Google Scholar
P. Zimmet, K. G. Alberti, F. Kaufman et al., “The metabolic syndrome in children and adolescents—an IDF consensus report,” Pediatric Diabetes, vol. 8, no. 5, pp. 299–306, 2007.
View at: Publisher Site | Google Scholar
L. Wilms, J. Larsen, P. L. Pedersen, and J. Kvetny, “Evidence of mitochondrial dysfunction in obese adolescents,” Acta Paediatrica, vol. 99, no. 6, pp. 906–911, 2010.
View at: Publisher Site | Google Scholar
U. Feldt-Rasmussen, “Thyroid and leptin,” Thyroid, vol. 17, no. 5, pp. 413–419, 2007.
View at: Publisher Site | Google Scholar
L. Pacifico, C. Anania, F. Ferraro, G. M. Andreoli, and C. Chiesa, “Thyroid function in childhood obesity and metabolic comorbidity,” Clinica Chimica Acta, vol. 413, no. 3-4, pp. 396–405, 2012.
View at: Publisher Site | Google Scholar
T. Reinehr, “Thyroid function in the nutritionally obese child and adolescent,” Current Opinion in Pediatrics, vol. 23, no. 4, pp. 415–420, 2011.
View at: Publisher Site | Google Scholar
J. M. Friedman and J. L. Halaas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998.
View at: Publisher Site | Google Scholar
M. I. Santos, C. Limbert, F. C. Marques, F. Rosario, and L. Lopes, “Childhood obesity, thyroid function, and insulin resistance—is there a link? A longitudinal study,” Journal of Pediatric Endocrinology & Metabolism, vol. 28, no. 5-6, pp. 557–562, 2015.
View at: Publisher Site | Google Scholar
E. A. Nillni, C. Vaslet, M. Harris, A. Hollenberg, C. Bjorbak, and J. S. Flier, “Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways,” Journal of Biological Chemistry, vol. 275, no. 46, pp. 36124–36133, 2000.
View at: Publisher Site | Google Scholar
C. S. Mantzoros, M. Ozata, A. B. Negrao et al., “Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans,” The Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 7, pp. 3284–3291, 2001.
View at: Publisher Site | Google Scholar
C. Menendez, R. Baldelli, J. P. Camiña et al., “TSH stimulates leptin secretion by a direct effect on adipocytes,” The Journal of Endocrinology, vol. 176, no. 1, pp. 7–12, 2003.
View at: Publisher Site | Google Scholar
M. A. Michalaki, A. G. Vagenakis, A. S. Leonardou et al., “Thyroid function in humans with morbid obesity,” Thyroid, vol. 16, no. 1, pp. 73–78, 2006.
View at: Publisher Site | Google Scholar
G. De Pergola, A. Ciampolillo, S. Paolotti, P. Trerotoli, and R. Giorgino, “Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women,” Clinical Endocrinology, vol. 67, no. 2, pp. 265–269, 2007.
View at: Publisher Site | Google Scholar
T. Reinehr, A. Isa, G. de Sousa, R. Dieffenbach, and W. Andler, “Thyroid hormones and their relation to weight status,” Hormone Research, vol. 70, no. 1, pp. 51–57, 2008.
View at: Publisher Site | Google Scholar
A. Cabanelas, P. C. Lisboa, E. G. Moura, and C. C. Pazos-Moura, “Leptin acute modulation of the 5-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats,” Hormone and Metabolic Research, vol. 38, no. 8, pp. 481–485, 2006.
View at: Publisher Site | Google Scholar
S. Shalitin, M. Yackobovitch-Gavan, and M. Phillip, “Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic parameters,” Hormone Research, vol. 71, no. 3, pp. 155–161, 2009.
View at: Publisher Site | Google Scholar
T. Ünüvar, A. Anık, G. Çatlı et al., “Isolated hyperthyrotropinemia in childhood obesity and its relation with metabolic parameters,” Journal of Endocrinological Investigation, vol. 37, no. 9, pp. 799–804, 2014.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2018 Won Kyoung Cho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

1444

Downloads

1101

Citations